Founded in 1964, the New York Blood Center (NYBC) is a non-profit organization based in New York, United States. The NYBC operates as one of the largest independent community-based blood centers in the country. Its headquarters is located in New York City.

The NYBC provides comprehensive blood and platelet services, including collection, processing, testing, and distribution of blood products to hospitals and healthcare facilities in the New York metropolitan area. In addition to providing blood for transfusions, the NYBC also conducts research and development to advance the field of transfusion medicine. It collaborates with various institutions and organizations to develop innovative technologies and therapies related to blood management and transfusion.

On a global scale, the NYBC has developed partnerships and affiliations with international blood centers and organizations. It has collaborated with the World Health Organization (WHO) and participated in initiatives aimed at improving blood safety and availability worldwide. Furthermore, the NYBC has formed alliances with blood centers in other countries to promote research, knowledge sharing, and support during emergencies or natural disasters.

As a prominent player in the blood banking industry, the NYBC holds a strong market position. It competes with other established blood centers and corporations in the United States. However, specific global sales figures or rankings among competitors are not readily available.

Over the years, the NYBC has achieved significant milestones and breakthroughs in the field of transfusion medicine. It has introduced advanced blood processing techniques and implemented measures to enhance the safety of donated blood. The NYBC actively participates in research and clinical trials to improve transfusion practices and develop new therapies.

Presently, the company continues to play a vital role in ensuring a stable and safe blood supply for patients in the New York metropolitan area. However, the latest updates or noteworthy information regarding the company's current status have not been found at this time